As the technology behind gene therapy products continues to evolve, applicants face the challenge of adapting their programmes to increasingly demanding and detailed regulation. This article provides an overview of current regulatory expectations and the challenges they may present to industry.
Join now to get access to:
Not sure yet? Read one of our free editorials to see what you’re missing out on!